Published 3 years ago

Medicover Hospitals Conduct Study On Safety, Efficacy Of Covid Vax

Summary by Ground News

13% people were infected (out of which 2.63% of people got admitted) after the 1st dosage and 2.83% were infected after the 2nd dosage. No deaths were reported and no case is reported with any clotting issues. All the infections are of mild in category and none of them were turned to moderate/severe category.

0 Articles

All

Left

Center

Right

Ommcom News

Medicover Hospitals Conduct Study On Safety, Efficacy Of Covid Vax

New Delhi: Medicover Hospitals has done a study on safety and efficacy of Covid vaccines -- Covaxin and Covishield. "We have done a detailed review and

3 years ago·Bhubaneswar, India

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated3 years agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Medicover Hospitals Conduct Study On Safety, Efficacy Of Covid Vax

0 Articles

0 Articles

Medicover Hospitals Conduct Study On Safety, Efficacy Of Covid Vax

Medicover Hospitals Conduct Study On Safety, Efficacy Of Covid Vax

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics